0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Sign in to save

The new era of cardiovascular research: revolutionizing cardiovascular research with 3D models in a dish

Medical Review 2024 4 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 55 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yuan Yang, Hao Yang, Fedir N. Kiskin, Joe Z. Zhang

Summary

This review explores how three-dimensional cell and tissue models grown in the laboratory are transforming cardiovascular research. Researchers describe advances in organoids, heart-on-chip devices, and 3D-printed tissue constructs that better mimic human heart and blood vessel biology than traditional animal models. The study highlights how these new models could accelerate the discovery of treatments for heart disease while reducing reliance on animal testing.

Body Systems
Models
Study Type In vitro

Cardiovascular research has heavily relied on studies using patient samples and animal models. However, patient studies often miss the data from the crucial early stage of cardiovascular diseases, as obtaining primary tissues at this stage is impracticable. Transgenic animal models can offer some insights into disease mechanisms, although they usually do not fully recapitulate the phenotype of cardiovascular diseases and their progression. In recent years, a promising breakthrough has emerged in the form of in vitro three-dimensional (3D) cardiovascular models utilizing human pluripotent stem cells. These innovative models recreate the intricate 3D structure of the human heart and vessels within a controlled environment. This advancement is pivotal as it addresses the existing gaps in cardiovascular research, allowing scientists to study different stages of cardiovascular diseases and specific drug responses using human-origin models. In this review, we first outline various approaches employed to generate these models. We then comprehensively discuss their applications in studying cardiovascular diseases by providing insights into molecular and cellular changes associated with cardiovascular conditions. Moreover, we highlight the potential of these 3D models serving as a platform for drug testing to assess drug efficacy and safety. Despite their immense potential, challenges persist, particularly in maintaining the complex structure of 3D heart and vessel models and ensuring their function is comparable to real organs. However, overcoming these challenges could revolutionize cardiovascular research. It has the potential to offer comprehensive mechanistic insights into human-specific disease processes, ultimately expediting the development of personalized therapies.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Multi-chamber cardioids unravel human heart development and cardiac defects

Researchers engineered a human cardioid platform that self-organizes into multi-chambered heart structures recapitulating all major embryonic compartments including left and right ventricles, atria, outflow tract, and atrioventricular canal. The platform enables direct study of genetic mutations and environmental factors including chemical exposures on human heart development in ways not possible with existing 2D or simpler 3D models.

Article Tier 2

Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D in vitro tissue models of disease

This review discusses how advanced three-dimensional tissue models grown in the laboratory could be combined with computational systems biology approaches to better study human diseases. Researchers argue that current analysis methods do not fully capture the complexity these tissue models offer, and that mathematical modeling could unlock deeper insights. The study outlines a framework for integrating these two fields to improve drug development and understanding of disease mechanisms.

Article Tier 2

Engineering Organ-on-a-Chip Systems for Vascular Diseases

This review covers organ-on-a-chip technology, which creates miniature models of blood vessels on microchips to study diseases like atherosclerosis and blood clots. While not directly about microplastics, this technology is increasingly being used to study how microplastics and nanoplastics affect human blood vessels and organs in controlled laboratory settings. These advanced models could help researchers better understand the health risks of microplastic exposure without relying solely on animal studies.

Article Tier 2

Neuropathogenesis-on-chips for neurodegenerative diseases

Researchers reviewed how miniaturized lab-on-a-chip devices that mimic brain tissue are being developed to study neurodegenerative diseases like Alzheimer's and Parkinson's, offering more realistic models than traditional animal tests. These microfluidic systems, combined with stem cells, could accelerate the discovery of new diagnostics and treatments for conditions that affect millions of people worldwide.

Article Tier 2

Application of organoid technology in the human health risk assessment of microplastics: A review of progresses and challenges

This review examines how organoid technology -- miniature lab-grown versions of human organs made from stem cells -- can be used to study the health effects of microplastics more accurately than traditional animal testing. Organoids of the gut, lung, brain, liver, and other organs can better predict how microplastics affect human tissues, potentially accelerating our understanding of the real health risks these particles pose.

Share this paper